Virtus ETF Advisers’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $68.9K | Buy |
|
|||||
|
2024
Q3 | $64.3K | Buy |
|
|||||
|
2024
Q2 | $71.9K | Buy |
|
|||||
|
2024
Q1 | $90.7K | Sell |
|
|||||
|
2023
Q4 | $95.8K | Sell |
|
|||||
|
2023
Q3 | $76.7K | Sell |
|
|||||
|
2023
Q2 | $82.4K | Sell |
|
|||||
|
2023
Q1 | $73.9K | Sell |
|
|||||
|
2022
Q4 | $118K | Sell |
|
|||||
|
2022
Q3 | $179K | Buy |
|
|||||
|
2022
Q2 | $136K | Buy |
|
|||||
|
2022
Q1 | $60K | Sell |
|
|||||
|
2021
Q4 | $151K | Buy |
|